MedPath

Treatment of Essential Hypertension Grade 2 with a Unani formulatio

Not Applicable
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Registration Number
CTRI/2021/05/033481
Lead Sponsor
Prof Rais Ur Rahman
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Diagnosed patients of either sex with age limit from 18 years to 65 years with Essential Hypertension Grade 2 as per ACC criteria

Patient willing to participate and sign the informed understood consent form

Exclusion Criteria

Secondary hypertension

Patient with sign of end organ damage

Patient taking OCP and long term use of steroids

Pregnant & lactating women

Renal and hepatic insufficiency

other Cardiovascular disorder

malignancy

Patient who unwilling to sign the consent form

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To develop safe efficacious and cost effective drug for the management of Essential hypertension from herbal sourceTimepoint: baseline <br/ ><br>7th day <br/ ><br>14th day <br/ ><br>21st day
Secondary Outcome Measures
NameTimeMethod
Expected Blood pressure target to achieve around 120/80 mm Hg plus minus 10 mm Hg during mental & physical restTimepoint: 7 th day <br/ ><br>14 th day <br/ ><br>21 st day
© Copyright 2025. All Rights Reserved by MedPath